We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
EnXray are developing Low Energy X-ray (LEXR) technologies to sterilise equipment in commercial or research settings where low volume/high value therapeutic products, such as cancer vaccines and stem cell implants are being developed. Their aim is to reduce the need for third party providers and have the sterilisation process done on-site and on-demand with simple and safe equipment to reduce cost and save time for medical research organisations.

Pitch Rated

61%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £376,230
Solivus is a solar technology company that aims to enable mega-buildings, homes and communities to lower their carbon footprint and generate local green energy through the company's proprietary solar solutions. Its patent-pending innovation, Solivus Arc, utilises thin-film solar technology to power homes and electric vehicles. The company asserts that Solivus Arc provides an alternative to rooftop solar and has incredible low-carbon credentials. Solivus aims to also enter the commercial and agricultural markets with its products. It will use 50% of the investment in product development and R&D, 40% in growing its team, and 10% towards legal and marketing costs.

Pitch Rated

83%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £1,619,048
OvuSense has been designed for women that struggle to conceive, actively predicting fertility patterns.  The OvuSense system has two parts a smartphone app and a medical grade vaginal sensor. OvuSense works for all women. The product gives a 24 hour prediction within your cycle.
days to go: Expired investment: £100,000
Please watch the video for more information
days to go: Expired investment: £607,175
Inspira Pharmaceuticals (IP) is forming a possible new therapy for COVID-19. IP asserts that its in-lab plant-based molecular formulation has killed over 95% of the SARS-CoV-2 virus. The company aims to understand whether a COVID-19 patient can safely inhale the formulation directly into their lungs as an effective treatment. IP has secured cornerstone investment from biotech angel investors and a Singaporean Venture Capitalist (VC) for its formula. IP argues that its technology has the potential for addressing other respiratory infections such as cystic fibrosis, influenza and the common cold in the coming months. The company will use the investment to develop an effective new drug, which will include further laboratory analysis, safety testing, and preparation for human trials.
days to go: Expired investment: £357,179
Plantwork Systems (PWS) is an eco-conscious, technology company providing sustainable and environmentally friendly solutions to the wastewater treatment industry. It is the developer, owner, and provider of a range of proprietary technologies such as TN-REM, NUTREM®, and the deHoxar Spiral Separator. These products aid in nutrient removal, improved filtration, sludge thickening. This leads to wastewater treatment plants recycling more water, reducing their energy requirements, and minimising water scarcity. The company has generated combined revenues of £1.44 million since July 2017. PWS is seeking funding of up to £1 million, at a pre-money valuation of £6 million. It will use the investment to accelerate its growth and bring more innovative products to the market. 

Pitch Rated

67%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £244,865
BiVictriX Therapeutics is a pharmaceutical company that are developing ADC's (Antibody Drug Conjugates) in the field of Oncology. They have invented a strategy that improves ADC selectivity towards cancer cells.
days to go: Expired investment: £451,506
Riversimple’s purpose it to pursue systemically the elimination of the environmental impact of personal transport.  They manufacture and develop environmentally friendly, clean, safe and fun hydrogen cars.  Their business model of a "sale of service contract" will mean they never sell a car and customers will have a contract of 1-3 years to include the cover of insurance and fuel.  They plan to trial 20 Rasa cars over 12 months in Monmouthshire and are crowdfunding to raise funds towards the build of 10 Beta cars.
days to go: Expired investment: £1,101,348
Marine Power Systems (MPS) is an innovative renewable energy company specializing in modular floating offshore wind technology, well-positioned to capitalize on the expanding worldwide potential of generating wind energy from advanced floating platforms. They have established revenue-generating agreements and secured significant grant funding, enabling them to further expand their team, enhance their customer pipeline, and undertake new commercial projects.
days to go: Expired investment: £2,880,994
Pioneering medical device company with patented technologies in the "key hole" surgery market 
days to go: Expired investment: £600,083
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph